FindTrial
Sign In

Intratumoral Fusobacterium nucleatum Is Associated with Tumor Immune Microenvironment and High-Risk Pathological Features in Early Colorectal Cancer: A Retrospective Study

Intratumoral Fusobacterium nucleatum Is Associated with Tumor Immune Microenvironment and High-Risk Pathological Features in Early Colorectal Cancer: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120359
Enrollment
Unknown
Registered
2026-03-12
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early colorectal cancer

Interventions

HGIN/T1 adenocarcinoma.:none

Sponsors

The First Hospital of Nanchang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathological diagnosis of early colorectal cancer ( HGIN or T1 adenocarcinoma ) 2.A complete FFPE pathological wax block 3.No preoperative radiotherapy or chemotherapy.

Exclusion criteria

Exclusion criteria: 1.Inflammatory bowel disease-associated cancer 2.Hereditary colorectal cancer syndrome 3.Pathological tissue volume is not enough to complete the test.

Design outcomes

Primary

MeasureTime frame
FN status ( positive / negative );Immune cell density (CD8, FOXP3);—

Countries

China

Contacts

Public ContactPeng Liu

The First Hospital of Nanchang

344840623@qq.com+86 791 8886 2387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026